Metabolic response of microglia to amyloid deposition during Alzheimer's disease progression in a mouse model

• Published in: bioRxiv
• Main Authors: Marino, Kaitlyn M, Squirrell, Jayne M, Chacko, Jenu V, Watters, Jyoti W, Eliceiri, Kevin W, Ulland, Tyler K
• Format: Journal Article
• Language: English
• Published: United States 12.05.2023
• Subjects: NADPH; fluorescence lifetime microscopy; glycolysis; FLIM; metabolism; aging; dystrophy; microglia; Alzheimer’s
• ISSN: 2692-8205; 2692-8205
• DOI: 10.1101/2023.05.12.540407

Alzheimer's disease (AD) drives metabolic changes in the central nervous system (CNS). In AD microglia are activated and proliferate in response to amyloid β plaques. To further characterize the metabolic changes in microglia associated with plaque deposition , we examined cortical tissue from 2, 4, and 8-month-old wild type and 5XFAD mice, a mouse model of plaque deposition. 5XFAD mice exhibited progressive microgliosis and plaque deposition as well as changes in microglial morphology and neuronal dystrophy. Multiphoton-based fluorescent lifetime imaging microscopy (FLIM) metabolic measurements showed that older mice had an increased amount of free NAD(P)H, indicative of a shift towards glycolysis. Interestingly in 5XFAD mice, we also found an abundant previously undescribed third fluorescence component that suggests an alternate NAD(P)H binding partner associated with pathology. This work demonstrates that FLIM in combination with other quantitative imaging methods, is a promising label-free tool for understanding the mechanisms of AD pathology.